Integral assessment of risk factors for death due to COVID-19

KHALILOVA Dilovar Zakhiriddin qizi, KHAYDAROVA Feruza Alimovna, ALIEVA Anna Valerevna

Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali · 2023-yil

Annotatsiya

Background. The COVID-19 pandemic has shown that people with non-communicable chronic diseases, in particular diabetes mellitus, are the most vulnerable to viral infection. It is of practical interest to search for risk factors for adverse outcomes of COVID-19 in patients with diabetes mellitus. Aim: Integral assessment of risk factors for death due to COVID-19. Materials and methods. A retrospective analysis of the features of the clinical course of COVID-19 depending on the presence or absence of DM was carried out on the basis of data from 5123 patients after a confirmed infection with SARS-CoV-2. Results and discussion. The presence of diabetes mellitus significantly increased the risk of death by 4.33 times, the male gender was 3.70 times more at risk of death due to coronavirus infection, the presence of obesity increased the risk of death by 2.99 times, the presence of coronary artery disease - by 5.63 times, the presence of hypertension - 1.85 times, the need for the use of glucocorticoids - understandably, occurred more often in patients with a severe course of a viral infection, so the risk of death in such patients was 1.48 times higher. More than 5 years of experience increased the risk of death by 3.91 times. It should be noted that among the dead there were no patients with diabetes experience less than 1 year. Male sex was also a significant risk factor for patients with type 2 diabetes with a RR of death of 5.03. The presence of coronary artery disease increased the risk of death due to coronavirus infection by 4.2 times among patients with type 2 diabetes. However, with regard to weight, its contribution to the increased risk of death among patients with type 2 diabetes was not significant. Also, the presence of hypertension in patients with type 2 diabetes did not increase the risk of death due to COVID-19, in contrast to the general population. In the case of patients with type 2 diabetes, the use of glucocorticoids, on the contrary, was protective - the RR of death was 2.9 times higher in those patients who did not receive glucocorticoids. Conclusion. The presence of diabetes mellitus, male gender, the presence of obesity, arterial hypertension and IBA significantly increased the risk of death due to COVID-19 in the general population. For patients with diabetes, the risk of death due to COVID-19 increases with an increase in the duration of diabetes above 5 years, the risk is higher in men, as well as in the presence of coronary artery disease. Patients with diabetes require careful monitoring and risk assessment for COVID-19 disease.

Maqola ma’lumotlari
MualliflarKHALILOVA Dilovar Zakhiriddin qizi, KHAYDAROVA Feruza Alimovna, ALIEVA Anna Valerevna
JurnalJournal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali
NashriyotТошкент давлат стоматалогия институти, , «Expert Lawyers» MЧЖ
ISSN2181-9300
Nashr sanasi2023-02-08
Jild7
Son6
TilIngliz
Ilmiy sohaTibbiyot
Indeksga qo‘shilgan2026-08-27

Maqolaning asl sahifasi

Kalit so‘zlar

сахарный диабет, риск летального исхода, COVID-19, diabetes mellitus, risk of lethal outcomes, COVID-19, diabet, COVID-19, kasallik og’irligi, o'lim havfi

Ilmiy soha

Tibbiyot

Iqtibos keltirish

APAKHALILOVA Dilovar Zakhiriddin qizi, KHAYDAROVA Feruza Alimovna, & ALIEVA Anna Valerevna (2023). INTEGRAL ASSESSMENT OF RISK FACTORS FOR DEATH DUE TO COVID-19. Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali, 7(6). https://tadqiqot.uz/index.php/biomedicine/article/view/6783
GOST (OAK)KHALILOVA Dilovar Zakhiriddin qizi, KHAYDAROVA Feruza Alimovna, ALIEVA Anna Valerevna INTEGRAL ASSESSMENT OF RISK FACTORS FOR DEATH DUE TO COVID-19 // Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali. – 2023. – T. 7, № 6.
MLAKHALILOVA Dilovar Zakhiriddin qizi, KHAYDAROVA Feruza Alimovna, and ALIEVA Anna Valerevna. “INTEGRAL ASSESSMENT OF RISK FACTORS FOR DEATH DUE TO COVID-19.” Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali, 7(6), 2023. https://tadqiqot.uz/index.php/biomedicine/article/view/6783
ChicagoKHALILOVA Dilovar Zakhiriddin qizi, KHAYDAROVA Feruza Alimovna, and ALIEVA Anna Valerevna. “INTEGRAL ASSESSMENT OF RISK FACTORS FOR DEATH DUE TO COVID-19.” Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali, 7(6) (2023). https://tadqiqot.uz/index.php/biomedicine/article/view/6783
HarvardKHALILOVA Dilovar Zakhiriddin qizi, KHAYDAROVA Feruza Alimovna, and ALIEVA Anna Valerevna (2023) ‘INTEGRAL ASSESSMENT OF RISK FACTORS FOR DEATH DUE TO COVID-19’, Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali, 7(6). https://tadqiqot.uz/index.php/biomedicine/article/view/6783
BibTeX
@article{khalilovadilovarzakhiriddinqizi2023,
  title = {INTEGRAL ASSESSMENT OF RISK FACTORS FOR DEATH DUE TO COVID-19},
  author = {KHALILOVA Dilovar Zakhiriddin qizi and KHAYDAROVA Feruza Alimovna and ALIEVA Anna Valerevna},
  journal = {Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali},
  year = {2023},
  volume = {7},
  number = {6},
  url = {https://tadqiqot.uz/index.php/biomedicine/article/view/6783}
}

Boshqa maqola uchun iqtibos tayyorlash

Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali jurnalidan boshqa maqolalar

Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali — barcha maqolalar · 2023-yil arxivi

Tibbiyot sohasidagi boshqa maqolalar

Tibbiyot sohasidagi OAK jurnallari